IL1B and neoplasm: Additionally, certain cytokines like PGE2 and IL-1β interact closely with TAMs in the tumor microenvironment, positioning the PGE2—IL-1β axis as a promising therapeutic target for PDAC (Whitmore and Lamont 2014).